CHANTEE WYATT: Open Payments
NPI 1104135326 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 19 payments from 9 companies in 2025. Trend: 2023 $256 · 2024 $236 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Amgen Inc. | 3 | $66 |
| Exact Sciences Corporation | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Medtronic, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Ascensia Diabetes Care Us Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, EVENITY, The Cologuard Plus Collection Kit, REXULTI, INCEPTIV, SPRAVATO, XIFAXAN.
Industry payments across UT — which companies pay providers there.
